Stock CYTRX CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News CytRx Corporation Nasdaq

Equities

US2328286081

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
FDA Acceptance of Zevra's Arimoclomol NDA Filing for Niemann-Pick Disease Type C Results in XOMA Making a $1 Million Milestone Payment to LadRx
AQ
Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol
DJ
LadRx Issues 2024 Update to Shareholders
BU
LadRx: Q3 Earnings Snapshot
AQ
LadRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
LadRx : Modification to Rights of Security Holders - Form 8-K
PU
LadRx: Q2 Earnings Snapshot
AQ
LadRx Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Investor Presentation: July 2023
PU
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation
BU
LadRx Announces Reverse Stock Split Effective as of May 17, 2023
BU
Reverse Split: 1 of 100
FA
LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
LadRx Announces Reverse Stock Split
BU
LadRx Corporation has filed an IPO in the amount of $24 million.
CI
LadRx Highlights Patent Issued for Its LADR Technology
BU
LadRx Highlights Patent Issued for Its LADR Technology
CI
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LADX Stock
  4. Stock
  5. News CytRx Corporation